1. Home
  2. CGEM vs TEN Comparison

CGEM vs TEN Comparison

Compare CGEM & TEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • TEN
  • Stock Information
  • Founded
  • CGEM 2016
  • TEN 1993
  • Country
  • CGEM United States
  • TEN Greece
  • Employees
  • CGEM N/A
  • TEN N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • TEN
  • Sector
  • CGEM Health Care
  • TEN
  • Exchange
  • CGEM Nasdaq
  • TEN NYSE
  • Market Cap
  • CGEM 506.1M
  • TEN 496.6M
  • IPO Year
  • CGEM 2021
  • TEN N/A
  • Fundamental
  • Price
  • CGEM $7.51
  • TEN $17.05
  • Analyst Decision
  • CGEM Strong Buy
  • TEN Buy
  • Analyst Count
  • CGEM 8
  • TEN 2
  • Target Price
  • CGEM $32.86
  • TEN $31.00
  • AVG Volume (30 Days)
  • CGEM 400.4K
  • TEN 285.4K
  • Earning Date
  • CGEM 05-14-2025
  • TEN 03-27-2025
  • Dividend Yield
  • CGEM N/A
  • TEN 8.79%
  • EPS Growth
  • CGEM N/A
  • TEN N/A
  • EPS
  • CGEM N/A
  • TEN 5.03
  • Revenue
  • CGEM N/A
  • TEN $804,061,000.00
  • Revenue This Year
  • CGEM N/A
  • TEN N/A
  • Revenue Next Year
  • CGEM $278.37
  • TEN $9.03
  • P/E Ratio
  • CGEM N/A
  • TEN $3.42
  • Revenue Growth
  • CGEM N/A
  • TEN N/A
  • 52 Week Low
  • CGEM $7.30
  • TEN $15.05
  • 52 Week High
  • CGEM $30.19
  • TEN $31.48
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 31.21
  • TEN 53.17
  • Support Level
  • CGEM $8.01
  • TEN $15.94
  • Resistance Level
  • CGEM $9.16
  • TEN $17.50
  • Average True Range (ATR)
  • CGEM 0.46
  • TEN 0.72
  • MACD
  • CGEM -0.04
  • TEN 0.12
  • Stochastic Oscillator
  • CGEM 9.62
  • TEN 80.35

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About TEN TSAKOS ENERGY NAVIGATION

Tsakos Energy Navigation Ltd is a seaborne transportation service provider for crude oil and petroleum products. The company's carriers cater to national and international independent oil companies and refiners. It generates revenue through charter contracts with its clients, which include time, bareboat, and voyage charters, contracts of affreightment, and pool arrangements.

Share on Social Networks: